Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

564
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

553
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
553
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

689
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.0K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.0K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

997
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
997
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

930
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
930

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.

The New England journal of medicine·2026
Same author

Longitudinal Observational Study of Cardiac Outcome Risk Factor Prediction in Children, Adolescents, and Adults with Barth Syndrome.

Pediatric cardiology·2022
Same author

Uncovering "bipolar blindness" with high-density orthogonal mapping at the scar-related critical isthmus in repaired congenitally corrected transposition of the great arteries.

HeartRhythm case reports·2021
Same author

Cardiac transplantation in children and adolescents with long QT syndrome.

Heart rhythm·2017
Same author

Artefactual atrial flutter due to interference from a portable media device.

Cardiology in the young·2015
Same author

Impaired cardiac reserve and severely diminished skeletal muscle O₂ utilization mediate exercise intolerance in Barth syndrome.

American journal of physiology. Heart and circulatory physiology·2011
Same journal

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

Cardiology in the young·2026
Same journal

Evaluation of clinical, laboratory, and epidemiological features of children with Kawasaki disease.

Cardiology in the young·2026
Same journal

The Pediatric Inventory for Parents: an evaluation of the Norwegian translation applied to mothers of infants with CHD.

Cardiology in the young·2026
Same journal

Financial fragility in adults with CHD: a report from the CHD Project to Understand Lifelong Survivor Experience.

Cardiology in the young·2026
Same journal

Prone back electrocardiogram in healthy children: comparison with routine supine electrocardiogram.

Cardiology in the young·2026
Same journal

Impact of conotruncal anomalies on outcomes following total cavopulmonary connection.

Cardiology in the young·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.9K

How implantable cardioverter-defibrillators work and simple programming.

Randall M Bryant1

  • 1Interventional Electrophysiology and Pacing,University of Florida - Jacksonville/Gainesville,Jacksonville,Florida,United States of America.

Cardiology in the Young
|January 14, 2017
PubMed
Summary
This summary is machine-generated.

The implantable cardioverter-defibrillator (ICD) was developed to prevent sudden cardiac death. This life-saving device monitors heart rhythms and delivers electrical shocks to correct dangerous arrhythmias.

Keywords:
Implantable cardiovertor-defibrillatordefibrillationventricular fibrillationventricular tachycardia

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Related Experiment Videos

Last Updated: Mar 8, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.9K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Area of Science:

  • Biomedical Engineering
  • Cardiology
  • Medical Devices

Background:

  • The implantable cardioverter-defibrillator (ICD) was invented by Dr. Michel Mirowski in 1966, following a personal tragedy.
  • Early experimental models and successful canine testing paved the way for human implantation.
  • The initial concept aimed to protect patients at high risk of sudden coronary death from ventricular fibrillation.

Purpose of the Study:

  • To review the historical development and technological evolution of the ICD.
  • To explain the internal mechanisms and functionalities of modern ICDs.
  • To highlight the advancements that have made ICDs sophisticated and life-saving medical devices.

Main Methods:

  • Historical review of pioneering work and key milestones in ICD development.
  • Description of early experimental models and human implantations.
  • Analysis of technological innovations in circuitry, battery, and capacitor technologies.

Main Results:

  • The first experimental ICD model was developed by 1969, with successful transvenous defibrillation.
  • The first human ICD implants were reported in 1980, capable of monitoring and treating arrhythmias.
  • Current ICDs are significantly smaller and more advanced than the original devices.

Conclusions:

  • The ICD has evolved from an experimental concept to a sophisticated, miniaturized medical device.
  • Continuous technological advancements have enhanced ICD efficacy and patient protection.
  • ICDs play a crucial role in preventing sudden cardiac death in at-risk individuals.